Healthcare Co., Ltd. (603313.SS)
CNY 6.71
(-3.87%)
CNY 6.71
(-3.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 884.17 Million CNY | 28.35% |
| 2022 | 918.5 Million CNY | 121.37% |
| 2021 | 355.09 Million CNY | -49.5% |
| 2020 | 830.94 Million CNY | 7.84% |
| 2019 | 613.69 Million CNY | 91.66% |
| 2018 | 332.35 Million CNY | 36.46% |
| 2017 | 246.21 Million CNY | -10.95% |
| 2016 | 279.22 Million CNY | 23.51% |
| 2015 | 220.55 Million CNY | 33.02% |
| 2014 | 167.62 Million CNY | 13.92% |
| 2013 | 147.4 Million CNY | 4.75% |
| 2012 | 142.95 Million CNY | 24.93% |
| 2011 | 114.31 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -218.81 Million CNY | -281.26% |
| 2024 Q1 | 105.93 Million CNY | -40.32% |
| 2024 Q2 | 120.72 Million CNY | -19.63% |
| 2023 FY | - CNY | 28.35% |
| 2023 Q3 | 126.64 Million CNY | -18.38% |
| 2023 Q2 | 155.17 Million CNY | 86.66% |
| 2023 Q4 | 138.25 Million CNY | 9.16% |
| 2023 Q1 | 83.13 Million CNY | 1270.72% |
| 2022 FY | - CNY | 121.37% |
| 2022 Q4 | 6.06 Million CNY | -92.86% |
| 2022 Q1 | 110.85 Million CNY | 787.78% |
| 2022 Q2 | 140.13 Million CNY | 26.41% |
| 2022 Q3 | 84.93 Million CNY | -39.39% |
| 2021 Q4 | -16.11 Million CNY | 85.95% |
| 2021 Q2 | 11.4 Million CNY | -90.04% |
| 2021 Q1 | 114.47 Million CNY | 122.22% |
| 2021 FY | - CNY | -49.5% |
| 2021 Q3 | -114.73 Million CNY | -1105.95% |
| 2020 FY | - CNY | 7.84% |
| 2020 Q3 | 268.03 Million CNY | 129.95% |
| 2020 Q2 | 116.56 Million CNY | -10.82% |
| 2020 Q4 | 51.51 Million CNY | -80.78% |
| 2020 Q1 | 130.71 Million CNY | -17.43% |
| 2019 Q2 | 141.1 Million CNY | 73.85% |
| 2019 Q4 | 158.3 Million CNY | -24.28% |
| 2019 Q1 | 81.16 Million CNY | 3.82% |
| 2019 FY | - CNY | 91.66% |
| 2019 Q3 | 209.05 Million CNY | 48.16% |
| 2018 Q2 | 53.62 Million CNY | 228.26% |
| 2018 FY | - CNY | 36.46% |
| 2018 Q4 | 78.17 Million CNY | -34.11% |
| 2018 Q3 | 118.64 Million CNY | 121.25% |
| 2018 Q1 | 16.33 Million CNY | 320.82% |
| 2017 Q4 | -7.39 Million CNY | -111.7% |
| 2017 FY | - CNY | -10.95% |
| 2017 Q2 | 78.29 Million CNY | 20.81% |
| 2017 Q3 | 63.2 Million CNY | -19.27% |
| 2017 Q1 | 64.8 Million CNY | -1.16% |
| 2016 Q3 | 72.4 Million CNY | 41.26% |
| 2016 Q1 | 62.41 Million CNY | -5.92% |
| 2016 Q4 | 65.56 Million CNY | -9.44% |
| 2016 FY | - CNY | 23.51% |
| 2016 Q2 | 51.25 Million CNY | -17.88% |
| 2015 FY | - CNY | 33.02% |
| 2015 Q4 | 66.34 Million CNY | 14.67% |
| 2015 Q3 | 57.85 Million CNY | 0.0% |
| 2014 FY | - CNY | 13.92% |
| 2013 FY | - CNY | 4.75% |
| 2012 FY | - CNY | 24.93% |
| 2011 FY | - CNY | 0.0% |